Merck Sharp & Dohme extends contract with Kuehne + Nagel

30/11/2015

Merck Sharp & Dohme (MSD), one of the world’s leading pharmaceutical companies, has extended its overland contract with Kuehne + Nagel in Europe, Middle East, Africa (EMEA) and North America for another two years.

To read this article you need to subscribe.

Help us to continue to invest in award-winning independent journalism. For an introductory offer of just £70 a year, or £10 per month, get access to all our daily news stories and opinion. If you are already a registered user, please login below with your current account's email and password to subscribe. If you are not registered and want to subscribe, please register below to subscribe.

Current subscriber

New subscriber